Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mott

Showing results (81-90 of 254) with videos related to

Pageof 26
Sort By:
Molecular and Cellular Endocrinology|February 1, 2017
Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cellsPenn Muluhngwi, Kirsten Richardson, Joshua Napier, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 21, 2005
Mitochondrial DNA mutations activate programmed cell survival in the mouse heartDekui Zhang, Justin L Mott, Shin-Wen Chang, et al.
RNA Biology|December 30, 2017
miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor familyCody J Wehrkamp, Sathish Kumar Natarajan, Ashley M Mohr, et al.
Urologic Oncology|August 30, 2018
Nongenitourinary complications associated with robot-assisted laparoscopic and radical retropubic prostatectomy: A single institution assessment of 1,100 patients over 11 yearsNathan A Brooks, Riley S Boland, Michael E Strigenz, et al.
Expert Opinion on Pharmacotherapy|February 23, 2024
Impact of bladder cancer family history on the prognosis of patients with non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)Mohamad Abou Chakra, Igor Duquesne, Michael Peyromaure, et al.
Annals of Surgical Oncology|December 1, 2024
Patterns of Care and Oncologic Outcomes after Pelvic Exenteration for Locally Advanced Rectal Cancer in the United StatesAlexander Troester, Lauren Weaver, Sarah L Mott, et al.
Urologic Oncology|November 26, 2024
The efficacy of sequential intravesical gemcitabine and docetaxel versus BCG for the treatment of European association of urology very-high risk non-muscle invasive bladder cancerMohamad Abou Chakra, Vignesh T Packiam, Ian M McElree, et al.
Urologic Oncology|May 25, 2024
Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancerMohamad Abou Chakra, Ian M McElree, Vignesh T Packiam, et al.
Physics in Medicine and Biology|February 18, 2005
Quantitative analysis of patient-specific dosimetric IMRT verificationG J Budgell, B A Perrin, J H L Mott, et al.
Molecular Cancer Therapeutics|August 30, 2008
BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosisJustin L Mott, Steve F Bronk, Ruben A Mesa, et al.
Pageof 26

Showing results (81-90 of 254) with videos related to

Sort By:
Pageof 26
Molecular and Cellular Endocrinology|February 1, 2017
Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cellsPenn Muluhngwi, Kirsten Richardson, Joshua Napier, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 21, 2005
Mitochondrial DNA mutations activate programmed cell survival in the mouse heartDekui Zhang, Justin L Mott, Shin-Wen Chang, et al.
RNA Biology|December 30, 2017
miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor familyCody J Wehrkamp, Sathish Kumar Natarajan, Ashley M Mohr, et al.
Urologic Oncology|August 30, 2018
Nongenitourinary complications associated with robot-assisted laparoscopic and radical retropubic prostatectomy: A single institution assessment of 1,100 patients over 11 yearsNathan A Brooks, Riley S Boland, Michael E Strigenz, et al.
Expert Opinion on Pharmacotherapy|February 23, 2024
Impact of bladder cancer family history on the prognosis of patients with non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)Mohamad Abou Chakra, Igor Duquesne, Michael Peyromaure, et al.
Annals of Surgical Oncology|December 1, 2024
Patterns of Care and Oncologic Outcomes after Pelvic Exenteration for Locally Advanced Rectal Cancer in the United StatesAlexander Troester, Lauren Weaver, Sarah L Mott, et al.
Urologic Oncology|November 26, 2024
The efficacy of sequential intravesical gemcitabine and docetaxel versus BCG for the treatment of European association of urology very-high risk non-muscle invasive bladder cancerMohamad Abou Chakra, Vignesh T Packiam, Ian M McElree, et al.
Urologic Oncology|May 25, 2024
Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancerMohamad Abou Chakra, Ian M McElree, Vignesh T Packiam, et al.
Physics in Medicine and Biology|February 18, 2005
Quantitative analysis of patient-specific dosimetric IMRT verificationG J Budgell, B A Perrin, J H L Mott, et al.
Molecular Cancer Therapeutics|August 30, 2008
BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosisJustin L Mott, Steve F Bronk, Ruben A Mesa, et al.
Pageof 26